Certara Inc. is a prominent player in the biopharmaceutical industry, specializing in biosimulation and regulatory software to accelerate drug discovery, development, and approval processes. Its prima... Certara Inc. is a prominent player in the biopharmaceutical industry, specializing in biosimulation and regulatory software to accelerate drug discovery, development, and approval processes. Its primary function is to provide advanced technology solutions that streamline the journey of potential therapies from laboratory to market. Certara offers sophisticated modeling and simulation software that assists pharmaceutical companies in predicting drug behavior and efficacy, thereby enhancing decision-making and reducing development costs. Notable features of Certara’s offerings include its comprehensive suite of platforms like Simcyp and Phoenix, which are widely adopted for pharmacokinetic/pharmacodynamic (PK/PD) modeling and clinical trial analysis. The company serves a critical role in the life sciences sector by helping to bring new medicines to patients more efficiently. Certara’s impact is significant as it actively collaborates with major pharmaceutical and biotech companies globally, solidifying its position as a vital contributor to the advancement of healthcare and therapeutic innovation.
Pending data availability
EU Taxonomy Data missing for Certara
We haven’t collected EU Taxonomy data for Certara yet, or the company
hasn’t made it publicly available.